$80.43 0.00 (%) Covance Inc - NYSE

Oct. 23, 2014 | 04:00 PM

Partner Headlines

  1. Contract Researcher Parexel Sees Growth In Biotech

    IBD | Aug. 21, 2014 | 15:00PM EST
  2. WuXi Leverages China's Drug Strength As Outsourcer

    IBD | Feb. 7, 2014 | 18:31PM EST
  3. Morgan Stanley Sees Improving Early Stage for Covance

    Benzinga | Feb. 5, 2014 | 10:11AM EST
  4. Covance Board Authorizes $100M Stock Buyback

    Benzinga | Dec. 19, 2013 | 16:15PM EST
  5. Covance NeoGenomics Enter Strategic Alliance for Anatomic Pathology and Specialty Laboratory Testing Services

    Benzinga | Nov. 18, 2013 | 07:09AM EST
  6. Parexel Plunges After 3 CROs Report Earnings

    IBD | Oct. 30, 2013 | 11:41AM EST
  7. FBN at the Forbes Healthcare Summit

    FoxBusiness | Oct. 10, 2013 | 08:29AM EST
  8. Covance Announces $250M Long-Term Private Placement Debt Financing

    Benzinga | Oct. 8, 2013 | 16:04PM EST
  9. Parexel Stock Rises As Analyst Upgrades, Touts CROs

    IBD | Oct. 4, 2013 | 12:25PM EST
  10. Benzinga's Top Initiations

    Benzinga | Sep. 24, 2013 | 07:44AM EST
  11. Medical Research Firms Tap Drug Development Trend

    IBD | Aug. 30, 2013 | 16:40PM EST
  12. Medical Research Firms Tap Drug Development Trend

    IBD | Aug. 30, 2013 | 16:40PM EST
  13. Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, ...

    GuruFocus | Aug. 2, 2013 | 11:25AM EST
  14. Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc. ...

    GuruFocus | Aug. 2, 2013 | 11:25AM EST
  15. Benzinga's Top Downgrades

    Benzinga | Aug. 1, 2013 | 07:38AM EST
  16. UPDATE: ISI Group Reiterates Neutral Rating, Raises PT on Covance

    Benzinga | Jan. 28, 2013 | 03:37AM EST
  17. UPDATE: Jefferies Reiterates Hold Rating, Raises PT on Covance

    Benzinga | Jan. 28, 2013 | 02:31AM EST
  18. UPDATE: J.P. Morgan Reiterates Overweight Rating, Raises PT on Covance

    Benzinga | Jan. 25, 2013 | 07:30AM EST
  19. UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Covance

    Benzinga | Jan. 14, 2013 | 07:11AM EST
  20. Top Narrow Based Indexes For January 14, 2013

    Benzinga | Jan. 14, 2013 | 03:29AM EST
  21. Four European Stocks Worth a Look Now (DLPH, ICLR, IR, LYB)

    Benzinga | Nov. 24, 2012 | 10:02AM EST
  22. Covance, Inc. (CVD) Chairman and CEO Joseph L Herring sells 40,800 Shares

    GuruFocus | Nov. 8, 2012 | 10:39AM EST
  23. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Lowest PEG Ratio

    Benzinga | Nov. 1, 2012 | 21:00PM EST
  24. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest ROA

    Benzinga | Jun. 28, 2012 | 20:05PM EST
  25. Covance Inc. Reports Operating Results (10-K)

    GuruFocus | Feb. 28, 2012 | 06:21AM EST
  26. Stocks Fall As Greek Talks Hit Another Bump With CF Industries (CF) and Priceline (PCLN) on the Move

    MarketIntelligenceCenter | Feb. 14, 2012 | 14:44PM EST
  27. UPDATE: Citigroup Downgrades Covance to Neutral

    Benzinga | Jan. 27, 2012 | 01:18AM EST
  28. Stocks Give Back Early Gains With Hess (HES) and Toll Brothers (TOL) on the Move

    MarketIntelligenceCenter | Jan. 26, 2012 | 14:33PM EST
  29. UPDATE: Goldman Sachs Downgrades Covance to Neutral

    Benzinga | Jan. 26, 2012 | 05:19AM EST
  30. Goldman Sachs Downgrades Covance to Neutral

    Benzinga | Jan. 25, 2012 | 23:10PM EST
  31. Covance Board Authorizes $300M Stock Buyback

    Benzinga | Jan. 25, 2012 | 09:09AM EST
  32. Biotechs, HMOs, Digital Records Push Aid Health Stocks

    IBD | Jan. 19, 2012 | 11:25AM EST
  33. UPDATE: Citigroup Maintains Buy, Lowers PT to $55 on Covance

    Benzinga | Jan. 13, 2012 | 00:49AM EST
  34. Stocks Mixed at Midday with Research in Motion (RIMM) and Walgreen (WAG) on the Move

    MarketIntelligenceCenter | Jan. 12, 2012 | 12:24PM EST
  35. Jefferies Lowers PT on Covance to $44

    Benzinga | Jan. 12, 2012 | 01:13AM EST
  36. Covance Reiterates Full Year 2011 Revenue and Pro Forma EPS

    Benzinga | Jan. 9, 2012 | 09:22AM EST
Trading Center